Thromboprophylaxis in pregnancy: Who and how?

Obstetrics and Gynecology Clinics of North America

Volumn 37, Issue 2, 2010, Pages 333-343

  Davis, Sarah M ^a   Branch, D Ware ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Pregnancy; Prophylaxis; Screening; Thrombophilia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD VESSEL INJURY; CESAREAN SECTION; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG PROTEIN BINDING; GESTATIONAL AGE; HUMAN; HYPERCOAGULABILITY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS; THROMBOSIS PREVENTION; VEIN EMBOLISM; VEIN THROMBOSIS; VENOUS STASIS; FEMALE; PREGNANCY COMPLICATION; REVIEW; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CESAREAN SECTION; FEMALE; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECURRENCE; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 79952013753     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2010.02.004     Document Type: Article

References (35)

1. Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance- United States, 1991-1999. In: Surveillance summaries. MMWR Surveill Summ 2003;52(No. SS-2):1-8.
2. Gherman RB, Goodwin TM, Leung B, et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999;94:730-4.
3. James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-5.
4. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143:697-706.
5. Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6:632-7.
6. Ginsberg JS, Brill-Edwards P, Burrows RF, et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 1992;67:519-20.
7. James AJ, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005;193:216-9.
8. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999;54:256-71.
9. Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy. Lancet 2009 Nov 3. DOI:10.1016/S0140-6736(09)60996-X.
10. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.
11. James KV, Lohr JM, Deshmukh RM, et al. Venous thrombotic complications of pregnancy. Cardiovasc Surg 1996;4(6):777-82.
12. Rabhi Y, Charras-Arthapignet C, Gris J, et al. Lower limb vein enlargement and spontaneous blood flow echogenicity are normal sonographic findings during pregnancy. J Clin Ultrasound 2000;28:407-13.
13. Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997;104:191-7.
14. Macklon NS, Greer IA. The deep venous system in the puerperium: an ultrasound study. Br J Obstet Gynaecol 1997;104:198-200.
15. Pettker CM, Lockwood CJ. Thromboembolic disorders. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 5th edition. Philadelphia: Churchill Livingstone; 2007. p. 1064-76.
16. Rousseau A, Favier R, Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 2009; 146(1):46-9.
17. Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006;95:401-13.
18. Kjellberg U, Anderson NE, Rosen S, et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999;81: 527-31.
19. Rosenkranz A, Hiden M, Leschnik B, et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 2008;99:331-7.
20. Clark P, Walker I. The phenomenon known as acquired activated protein C resistance. Br J Haematol 2001;114:767-73.
21. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008;6:905-12.
22. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005;132:171-96.
23. Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106:517-24.
24. Said JM, Higgins JR, Moses EK, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010;115: 5-13.
25. Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010;115:14-20.
26. The American College of Obstetricians and Gynecologists (ACOG). Thromboembolism in pregnancy. Practice Bulletin 19. Washington, DC: ACOG; 2000.
27. Lussana F, Dentali F, Abbate R, et al. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009;124:e19-25.
28. Royal College of Obstetricians and Gynaecologists (RCOG). Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No. 37. London: RCOG; 2009.
29. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 2004;351(3):268-77.
30. Dalen JE. Should patients with venous thromboembolism be screened for thrombophilia? Am J Med 2008;121(6):458-63.
31. Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med 2000;343: 1439-44.
32. Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133: 844-66.
33. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003;101(6):1333-44.
34. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thromb Haemost 2009;101(5):806-12.
35. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy. American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third edition). Reg Anesth Pain Med 2010;35:64-101.